The role of soluble biomarkers is further enhanced when considered alongside novel markers like sPD-1/sPD-L1, which are involved in immune regulation and could add significant value to the existing biomarker panels by providing insights into immune response and tumor immune evasion mechanisms. The gene discussed is HOXD13; the disease is neoplasm.